Fresenius Medical (UK) Performance
| 0H9X Stock | 45.50 0.05 0.11% |
On a scale of 0 to 100, Fresenius Medical holds a performance score of 13. The firm shows a Beta (market volatility) of 0.0679, which means not very significant fluctuations relative to the market. As returns on the market increase, Fresenius Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Fresenius Medical is expected to be smaller as well. Please check Fresenius Medical's mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Fresenius Medical's price patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fresenius Medical Care are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Fresenius Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0294 | Payout Ratio 0.5299 | Last Split Factor 3:1 | Last Split Date 2007-06-18 |
1 | Reasons to Retain Fresenius Medical Stock in Your Portfolio Now - Yahoo Finance | 09/27/2024 |
2 | Fresenius Medical Care AGs institutional investors lost 4.8 percent over the past week but have profited from longer-term gains - Simply Wall St | 10/14/2024 |
3 | Are Investors Undervaluing Fresenius Medical Care AG Co. Right Now - MSN | 12/06/2024 |
Fresenius |
Fresenius Medical Relative Risk vs. Return Landscape
If you would invest 3,799 in Fresenius Medical Care on September 13, 2024 and sell it today you would earn a total of 751.00 from holding Fresenius Medical Care or generate 19.77% return on investment over 90 days. Fresenius Medical Care is generating 0.296% of daily returns and assumes 1.6697% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Fresenius, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Fresenius Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresenius Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Fresenius Medical Care, and traders can use it to determine the average amount a Fresenius Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1773
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 0H9X | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.67 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Fresenius Medical is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fresenius Medical by adding it to a well-diversified portfolio.
Fresenius Medical Fundamentals Growth
Fresenius Stock prices reflect investors' perceptions of the future prospects and financial health of Fresenius Medical, and Fresenius Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fresenius Stock performance.
| Return On Equity | 0.0582 | ||||
| Return On Asset | 0.0298 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 24.41 B | ||||
| Revenue | 19.24 B | ||||
| Gross Profit | 5.31 B | ||||
| EBITDA | 2.42 B | ||||
| Net Income | 499 M | ||||
| Book Value Per Share | 46.43 X | ||||
| Cash Flow From Operations | 2.17 B | ||||
| Retained Earnings | 10.71 B | ||||
About Fresenius Medical Performance
Assessing Fresenius Medical's fundamental ratios provides investors with valuable insights into Fresenius Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Fresenius Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Fresenius Medical is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Fresenius Medical Care performance evaluation
Checking the ongoing alerts about Fresenius Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fresenius Medical Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 32.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Are Investors Undervaluing Fresenius Medical Care AG Co. Right Now - MSN |
- Analyzing Fresenius Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fresenius Medical's stock is overvalued or undervalued compared to its peers.
- Examining Fresenius Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fresenius Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fresenius Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fresenius Medical's stock. These opinions can provide insight into Fresenius Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.